Patients with MDS report more symptoms than physicians, indicating a communication gap in symptom assessment. Allogeneic hematopoietic stem cell transplantation is the only cure but is limited to ...

Luspatercept is emerging as a frontline option for lower-risk MDS patients, offering sustained transfusion independence with ...

Maria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving prognostication for patients with myelodysplastic syndromes" on 27 ...

Hypomethylating agents (HMAs) are underutilized in high-risk MDS patients, especially among older, female, and non-White individuals. Only 16.1% of Medicare patients with newly diagnosed MDS received ...

The targeted drug olutasidenib is highly effective in certain patients with myelodysplastic syndrome (MDS), a condition considered incurable without transplantation, according to a new clinical study ...

The National Comprehensive Cancer Network now recommends Rytelo for patients with myelodysplastic syndrome who require blood transfusions. The National Comprehensive Cancer Network (NCCN) now ...

Scientific advances are sometimes made from the stuff of failure. That may be the case in the blood cancers known as myelodysplastic syndromes (MDS). The story starts with a clinical trial of an ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...

Myelodysplastic syndromes/neoplasms (MDS) represent a heterogeneous group of clonal hematopoietic cell disorders with abnormal cellular maturation that results in ineffective hematopoiesis. This leads ...

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial We analyzed a cohort ...

Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting Myelodysplastic syndromes (MDS) ...

“We saw really quite remarkable outcomes in a very high-risk MDS population, not only in response rates, but also in blood count improvement, long duration of response and improved overall survival,” ...